Amoxicillin for Lyme Disease: Is 14 Days Enough?

Amoxicillin is a standard treatment for early Lyme disease
A 14-day course cleared erythema migrans in this study
Some patients later reported persistent symptoms despite treatment

Amoxicillin is one of the standard antibiotics used to treat early Lyme disease. In a study by Wormser and colleagues, a 14-day course successfully cleared erythema migrans (EM) rashes and prevented objective neurologic, cardiac, and rheumatologic complications. However, four of the 24 patients later developed persistent symptoms that met the investigators’ definition of post-treatment Lyme disease syndrome (PTLDS).

Wormser and colleagues evaluated 24 adults with erythema migrans, the characteristic rash associated with early Lyme disease. The patients were treated with 500 mg of amoxicillin three times daily for 14 days and followed for as long as one year.

Amoxicillin is commonly prescribed for adults and children with early Lyme disease and is one of several recommended first-line antibiotics for erythema migrans. Treatment decisions should always be individualized based on the patient’s age, allergies, pregnancy status, symptoms, and overall clinical picture.

Does amoxicillin treat Lyme disease?

Yes. Amoxicillin is one of the antibiotics commonly used to treat early Lyme disease. In this study, the authors concluded that a 14-day course was highly effective for adults presenting with erythema migrans.

According to the authors, treatment successfully resolved the patients’ erythema migrans rashes and “prevented the development of objective neurologic, cardiac, or rheumatologic manifestations.”

This is an important finding because untreated or inadequately treated Lyme disease may progress beyond the initial skin lesion and involve the nervous system, heart, or joints. Patients can learn more about the broader treatment process in my Lyme disease treatment guide.

What happened during follow-up?

One patient was retreated with another course of amoxicillin. Two additional patients could not be evaluated at the one-year follow-up because they developed recurrent erythema migrans rashes.

A recurrent erythema migrans rash may represent reinfection following another infected tick bite rather than failure of the original treatment. It can therefore complicate efforts to determine the long-term outcome of the initial antibiotic course.

Most of the patients did well based on the study’s objective clinical measures. Nevertheless, four of the 24 patients—approximately 17%—went on to meet the investigators’ definition of post-treatment Lyme disease syndrome (PTLDS).

Four patients developed persistent symptoms

The investigators described PTLDS as subjective symptoms attributed to Lyme disease that persisted continuously or intermittently for at least six months following completion of antibiotic treatment with amoxicillin.

The study did not establish why these patients remained ill. The possible explanations for persistent symptoms after Lyme disease treatment remain debated and may not be the same for every patient.

Proposed explanations include persistent infection, immune or inflammatory responses, residual tissue injury, autonomic dysfunction, unrecognized coinfections, reinfection, or another medical condition. The relative contribution of these mechanisms remains uncertain.

The absence of an objective neurologic, cardiac, or rheumatologic manifestation does not mean that fatigue, pain, cognitive difficulties, or other persistent symptoms are clinically unimportant.

Patients with ongoing illness may benefit from a careful reassessment rather than having their symptoms dismissed solely because the erythema migrans rash resolved. My overview of persistent Lyme disease discusses the clinical questions that can arise when symptoms continue after treatment.

Was the 14-day treatment a failure?

It would be too strong to conclude that every patient who developed persistent symptoms experienced antibiotic treatment failure. The study showed that amoxicillin successfully cleared the erythema migrans lesions and prevented the development of the objective complications measured by the investigators.

At the same time, approximately 17% of the study participants developed symptoms lasting at least six months. Whether these symptoms reflected persistent infection, an inflammatory or immune-mediated process, residual injury, another tick-borne infection, or a different mechanism was not determined.

Although most patients recovered, the proportion who experienced persistent symptoms remains an important clinical concern.

Could the rate of persistent symptoms be higher in clinical practice?

The study was small, involved only 24 patients, and was conducted at a single center. These limitations make it difficult to apply the results to every patient with an erythema migrans rash.

The proportion of patients with persistent or recurrent clinical problems after a 14-day course may differ in routine clinical practice, particularly among individuals with delayed diagnosis, more severe illness at presentation, or possible coinfections.

However, these groups were not specifically evaluated in this study. It is therefore more accurate to regard this as a clinical concern requiring further study rather than as a conclusion established by the trial.

The timing of treatment may also matter. Patients treated promptly for an uncomplicated erythema migrans rash may have different outcomes from patients whose diagnosis was delayed or whose illness had already progressed beyond the skin. My discussion of delayed Lyme disease treatment reviews why later recognition can complicate evaluation and recovery.

What is the cure rate for Lyme disease?

Most patients with early erythema migrans recover after appropriate antibiotic treatment. In this study, the rash resolved in all 24 participants, and no objective neurologic, cardiac, or rheumatologic complications developed during follow-up.

However, four of the 24 patients continued to report persistent symptoms lasting at least six months. These findings illustrate why clinical recovery cannot always be measured solely by disappearance of the rash and why ongoing follow-up may be appropriate for some patients.

How long should amoxicillin be taken for Lyme disease?

The appropriate antibiotic, dose, and duration depend on the patient’s age, clinical presentation, allergies, pregnancy status, disease manifestations, and other medical factors.

The study discussed here evaluated adults who received amoxicillin 500 mg three times daily for 14 days for erythema migrans. It did not evaluate every manifestation of Lyme disease and should not be used to determine treatment for patients with neurologic Lyme disease, Lyme carditis, Lyme arthritis, persistent symptoms, or suspected coinfections.

Patients should not begin, stop, or extend antibiotic treatment without discussing the potential benefits, limitations, and risks with their treating clinician.

What does this study tell us?

The study offers evidence that a 14-day course of amoxicillin can be effective for clearing an erythema migrans rash and preventing the objective complications monitored by the investigators.

It also demonstrates that resolution of the rash does not guarantee that every patient will remain symptom-free. Four patients developed persistent symptoms lasting at least six months despite completing the prescribed antibiotic course.

These findings support the need to evaluate the full clinical outcome rather than defining success only by disappearance of the rash or absence of a narrowly defined objective manifestation.

Editor’s note: “PTLDS” remains a controversial term that I do not endorse as an explanation for the underlying cause of persistent illness, particularly because there is no routinely available test that can prove that every viable Lyme bacterium has been eliminated.

Frequently Asked Questions

Does amoxicillin treat Lyme disease?

Yes. Amoxicillin is commonly used to treat early Lyme disease, including erythema migrans. The appropriate antibiotic and treatment duration depend on the patient’s clinical presentation and individual medical circumstances.

How effective is amoxicillin for an erythema migrans rash?

In this small study, a 14-day course of amoxicillin resolved the erythema migrans rash in all 24 participants and prevented the objective neurologic, cardiac, and rheumatologic manifestations monitored by the investigators.

How long is amoxicillin prescribed for Lyme disease?

The study evaluated amoxicillin 500 mg three times daily for 14 days in adults with erythema migrans. Treatment recommendations may differ for children, pregnant patients, people with medication allergies, and patients with neurologic, cardiac, arthritic, or persistent manifestations.

Can symptoms continue after amoxicillin treatment?

Yes. Four of the 24 patients in this study developed symptoms that persisted continuously or intermittently for at least six months and met the investigators’ definition of PTLDS.

Can amoxicillin prevent Lyme disease after a tick bite?

Unlike doxycycline, amoxicillin has not been established as a single-dose antibiotic for post-exposure prophylaxis following a tick bite. Decisions regarding preventive treatment should follow current clinical guidelines and an individualized assessment of Lyme disease risk.

Does a persistent Lyme disease rash mean treatment failed?

An erythema migrans rash generally fades after appropriate treatment, although the time required for complete resolution can vary. A new rash appearing later may represent reinfection rather than persistence of the original rash and should be evaluated clinically.

Is amoxicillin as effective as doxycycline for Lyme disease?

Both amoxicillin and doxycycline are used for early Lyme disease. The most appropriate choice depends on factors such as age, pregnancy, allergies, medication interactions, sun sensitivity, disease manifestations, and the possibility of another tick-borne infection.

Does disappearance of the rash prove Lyme disease has been cured?

No. Resolution of an erythema migrans rash is an encouraging clinical response, but it does not by itself prove that every patient has fully recovered. Follow-up should also consider persistent, recurrent, or newly developing symptoms.

Clinical Takeaway

A 14-day course of amoxicillin successfully resolved erythema migrans and prevented the objective neurologic, cardiac, and rheumatologic complications measured in this small study.

However, four of the 24 patients later developed persistent symptoms lasting at least six months. The study did not determine whether these symptoms reflected persistent infection, immune or inflammatory mechanisms, residual tissue injury, autonomic dysfunction, coinfection, reinfection, or another process.

The study also involved only 24 patients with uncomplicated erythema migrans, so the findings cannot necessarily be generalized to patients with delayed diagnosis, disseminated Lyme disease, neurologic involvement, Lyme carditis, Lyme arthritis, or coinfections.

Resolution of the erythema migrans rash is an important treatment milestone, but long-term clinical success should ultimately be judged by the patient’s symptoms, function, and overall recovery.

Related Articles

These articles explore antibiotic treatment, persistent symptoms, and other tick-borne infections that may influence recovery.

Lyme Disease Treatment: A Practical Guide
Persistent Lyme Disease: Understanding Ongoing Symptoms
The Best Antibiotics to Treat Borrelia miyamotoi
Could Dormancy Allow Lyme Disease to Survive Antibiotics?
More Problems with a 2-Week Course of Antibiotics for Lyme Disease

References

1. Wormser GP, Brady KC, Cho MS, Scavarda CA, McKenna D. Efficacy of a 14-day course of amoxicillin for patients with erythema migrans. Diagn Microbiol Infect Dis. 2019;94(2):192-194.
2. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis. 2021;72(1):e1-e48.
3. Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther. 2014;12(9):1103-1135.
4. Wormser GP. Commentary on persistent symptoms following treatment for erythema migrans. Diagn Microbiol Infect Dis. 2019.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention